Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.
Kaspera, Rüdiger
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. [electronic resource] - Biochemical pharmacology Sep 2011 - 681-91 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1873-2968
10.1016/j.bcp.2011.06.027 doi
Amino Acid Sequence
Animals
Aryl Hydrocarbon Hydroxylases--genetics
Catalysis
Cytochrome P-450 CYP2C8
Cytochromes b5--genetics
Escherichia coli--enzymology
Humans
In Vitro Techniques
Inactivation, Metabolic
Kinetics
Microsomes, Liver--drug effects
Models, Molecular
Molecular Sequence Data
NADPH-Ferrihemoprotein Reductase--genetics
Oxidation-Reduction
Pharmaceutical Preparations--metabolism
Polymorphism, Genetic
Protein Binding
Rats
Recombinant Proteins--genetics
Sequence Alignment
Substrate Specificity
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. [electronic resource] - Biochemical pharmacology Sep 2011 - 681-91 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1873-2968
10.1016/j.bcp.2011.06.027 doi
Amino Acid Sequence
Animals
Aryl Hydrocarbon Hydroxylases--genetics
Catalysis
Cytochrome P-450 CYP2C8
Cytochromes b5--genetics
Escherichia coli--enzymology
Humans
In Vitro Techniques
Inactivation, Metabolic
Kinetics
Microsomes, Liver--drug effects
Models, Molecular
Molecular Sequence Data
NADPH-Ferrihemoprotein Reductase--genetics
Oxidation-Reduction
Pharmaceutical Preparations--metabolism
Polymorphism, Genetic
Protein Binding
Rats
Recombinant Proteins--genetics
Sequence Alignment
Substrate Specificity